Lung dendritic cells were identified by immunohistochemistry in lung tissue sections from C57BL/6 mice. Following isolation from the lungs using CD11c magnetic beads, the flow cytometric analysis of I-A b؉ and CD11c
Disease caused by Mycobacterium tuberculosis continues to be the major cause of mortality from infectious disease worldwide (2) . While development of new chemotherapy as well as effective administration of current therapies may provide some reduction in the incidence of tuberculosis in the near term, in the longer term an effective vaccine against the disease would be preferred. However, while current innovation in new vaccine development is encouraging (16, 18, 19) , the field is still limited by a lack of precise knowledge of the host response, especially that regarding early events soon after exposure to the bacillus.
It is generally believed that the first cell to encounter M. tuberculosis in the lungs is the alveolar macrophage. If the macrophage is unable to kill the bacillus, it is thought that M. tuberculosis then somehow erodes into the interstitium, where it encounters other macrophages (how this happens is more a case of speculation [17] than of hard evidence) and thus establishes a site of infection. An influx of macrophages, probably of both local and blood-borne origin, then ensues, thickening the septa and giving rise to a local interstitial pneumonitis.
Acquired immunity is expressed relatively slowly in the lungs (5, 7). The reason for this is unclear, as is the site where the protective T cells become sensitized. The lymphoid tissues surrounding the bronchi are potential sites, but for these to be the sites, antigen has to be physically carried to these tissues due to the lack of lymphatic drainage to the mouse alveolus.
One type of myeloid cell capable of such an action is the dendritic cell. In the current study it is shown that CD11c-positive dendritic cells are well distributed throughout the alveolar region, with most exhibiting an immature phenotype when isolated and analyzed by flow cytometry. The study demonstrates that these cells are capable of phagocytosing live M. tuberculosis bacteria, leading to the secretion of interleukin-12 (IL-12) and stimulation of CD4 T cells to produce gamma interferon (IFN-␥). Given the knowledge (1, 25, 28 ) that dendritic cells are motile and capable of homing from the peripheral tissues to lymphoid organs, the data support the hypothesis that dendritic cells that engulf M. tuberculosis play an important role in the transition from the initial innate response in the lungs to a state of acquired specific immunity.
MATERIALS AND METHODS
Mice. Specific-pathogen-free C57BL/6 female mice (Jackson Laboratories, Bar Harbor, Maine) of 6 to 8 weeks of age were used.
Bacterium. M. tuberculosis strain H37Rv was grown from low-passage seed lots in Proskauer-Beck liquid medium containing 0.02% Tween 80 to mid-log phase then aliquoted and frozen at Ϫ70°C until use. The viability of the frozen stock was 8.3 ϫ 10 8 CFU/ml. Culture media. Dendritic cells were cultured in RPMI medium (cRPMI) consisting of RPMI 1640 medium (Sigma-Aldrich, Ltd., St. Louis, Mo.) supplemented with 1% glutamine, 0.1 mM nonessential amino acids (Life Technology, Grand Island, N.Y.), 50 M 2-mercaptoethanol (Sigma-Aldrich), 1% penicillinstreptomycin (Sigma-Aldrich), 10% fetal bovine serum (FBS), and 20 ng of recombinant murine granulocyte-macrophage colony-stimulating factor (GM-CSF) (Pepro Tech, Rocky Hill, N.J.) per ml. In some cultures tumor necrosis factor alpha (TNF-␣) (Pepro Tech) was added during the last 48 h of culture at a concentration of 10 ng/ml. RPMI medium lacking biotin and phenol red (dRPMI) (Irvine Scientific, Santa Ana, Calif.) was supplemented with 1% L-glutamine, 1% HEPES, 0.1% N 3 Na, and 2% FBS and was used to wash and stain cells during flow cytometric studies.
Phosphate-buffered saline (PBS) without calcium chloride and magnesium chloride (Life Technology) supplemented with 0.5% FBS was used to isolate and purify lung dendritic cells.
Identification of dendritic cells in lung sections from C57BL/6 mice. Lungs from C57BL/6 mice were inflated with 30% OCT (Tissue-Tek, Inc., Torrance, Calif.) in PBS through the trachea. After the lungs were removed from the pulmonary cavity, they were embedded in OCT and frozen in a bath of liquid nitrogen for a few seconds. Sections, 7 m thick, were cut on a cryostat (Leica, product no. CM 1850), fixed in cold acetone for 10 min, and air dried. These sections were incubated overnight at 4°C with monoclonal antibody (MAb) CD11c (N418) (Serotec, Oxford, United Kingdom), which specifically recognizes dendritic cells.
Bound antibody was detected using biotinylated goat anti-hamster immunoglobulin G (IgG) (BD PharMingen, San Diego, Calif.). Finally, the reaction was developed using alkaline phosphatase linked to avidin and new fuchsin (Biogenex, San Ramon, Calif.) as substrate. Sections were counterstained with Meyer's hematoxylin.
MAbs. MAbs specific for CD11c (N418) (Serotec) and CD11c (clone HL3, hamster IgG), CD11a (LFA-1, clone 2D7, rat IgG2a), CD11b (Mac-1, M1/70, rat IgG2a), MAC3 (clone M3/84, rat IgG1), I-A b (clone 9AFG-120, mouse IgG2a), CD54 (ICAM-1, clone 3E2, hamster IgG), CD40 (clone 3/23, rat IgG2a), CD86 (B7-2, clone GL1, rat IgG2a), CD80 (B7-1, clone 16-10A1, hamster IgG), rat IgG2a, rat IgG2b, rat IgG1, and hamster IgG were purchased from BD PharMingen as direct conjugates to fluorescein isothiocyanate (FITC), phycoerythrin, or biotin. In addition, MAb F4/80 (clone CI:A3-1, rat IgG2a) as direct conjugate to either FITC or phycoerythrin was purchased from Serotec together with its isotype control. Goat F(ab) 2 IgG anti-hamster IgG-FITC (Caltag, Burlingame, Calif.) and streptavidin conjugated to peridinin chlorophyll a protein (PerCP; Becton Dickinson, San Jose, Calif.) were used as secondary antibody where necessary.
Lung dendritic cell isolation. Isolation of lung dendritic cells was performed by modification of protocols already described by others (22) . Briefly, mice were euthanatized and the pulmonary cavities were opened. The blood circulatory system in the lungs was cleared by perfusion through the pulmonary artery with 3 ml of saline containing 50 U of heparin (Sigma-Aldrich) per ml. Lungs were aseptically removed and cut into small pieces in cold RPMI medium. The dissected tissue was then incubated in RPMI medium containing collagenase XI (0.7 mg/ml; Sigma-Aldrich) and type IV bovine pancreatic DNase (30 g/ml; Sigma-Aldrich) for 30 to 45 min at 37°C. The action of the enzymes was stopped by adding 10 ml of cRPMI, and digested lungs were further disrupted by gently pushing the tissue through a nylon screen. The single-cell suspension was then washed and centrifuged at 200 ϫ g. To lyse contaminating red blood cells, the cell pellet was incubated for 5 min at room temperature with 5 ml of Gey's solution (NH 4 Cl and KHCO 3 ). Cells were then washed with PBS containing 0.5% FBS, counted, and incubated at the appropriate ratio with MACS CD11c microbeads (Miltenyi Biotec, Auburn, Calif.) for 15 min at 6 to 12°C. After being washed again with 15 ml of PBS, cells were diluted in 5 ml of PBS containing 0.5% FBS. Finally, CD11c ϩ cells were separated by passing the antibody-coated cell suspension over a VS ϩ column on a SuperMACS magnetic cell separator. Positive cells were collected by removing the column from the magnetic field and then flushing it with PBS-0.5% FBS. Macrophages were removed from the CD11c ϩ cell population by plastic adherence incubation overnight at 37°C in a 5% CO 2 atmosphere. Thereafter, cells were washed with RPMI medium and used for further studies or cultured again for 7 days in cRPMI. Cultures were fed every 48 h.
Bone marrow-derived dendritic cells. Bone marrow-derived dendritic cells were prepared using a procedure similar to one described previously (11) . Briefly, mice were euthanatized by exposure to CO 2 atmosphere and their femurs were dissected out. After trimming the bones at both ends, the marrow was flushed out with cold cRPMI supplemented with 10% FBS. Cells were washed once in cRPMI and incubated at a concentration of 2 ϫ 10 5 cells/ml in cRPMI. The medium was changed at 48 h and replaced with cRPMI without antibiotics. After 7 days of incubation, dendritic cells were infected with M. tuberculosis as described below for lung dendritic cells.
Cell staining. Lung dendritic cells were isolated as discussed above and cultured either overnight or for 7 days at 37°C and 5% CO 2 . Cell suspensions of 5 ϫ 10 5 cells/ml were prepared and 100 l was centrifuged onto glass slides. To confirm adherent dendritic cell morphology, cells were cultured using Thermovox coverslips (Nalge Nunc International, Naperville, Ill.). Either cells centrifuged onto glass or cells adhered to plastic were stained using the Hema 3 stain set (Biochemical Science, Swedesboro, N.J.).
In vitro infection of lung dendritic cells. Purified lung dendritic cells from overnight or 7-day culture were cultured in 24-well plates at 2 ϫ 10 5 cells per ml in cRPMI without antibiotics and infected with M. tuberculosis (H37Rv strain) at a ratio of 5 or 10 bacilli per cell. At different times postinfection cells were washed, centrifuged onto glass slides as indicated above, and stained for acid-fast bacilli using Ziehl-Neelsen stain (Becton Dickinson Microbiology Systems, Sparks, Md.) or stained for cell surface markers and analyzed on a flow cytometer.
Flow cytometric analysis. Lung dendritic cells from either overnight or 7-day culture were washed in dRPMI. After blocking Fc receptors by using 1 g of anti-mouse CD16/CD32 MAb (Caltag) per 10 6 cells for 10 min on ice, cells were stained for 30 min on ice with purified or directly conjugated antibodies. Where necessary, cells were washed twice in dRPMI and incubated with an immunoglobulin-specific secondary antibody. Cell acquisition was performed on a FACScalibur (Becton Dickinson, Mountain View, Calif.) and data were analyzed using CellQuest software (Becton Dickinson).
Antigen stimulation of dendritic cells. Lung dendritic cells, either from overnight or 7-day culture, were incubated with 100 l of cRPMI (without GM-CSF) per well in 96-well plates. Cell number per well varied depending on the study: Stimulation of IFN-␥ production. The stimulatory activity of the lung dendritic cells was assessed by coculturing these cells with either naïve or immune CD4 T cells. Briefly, splenocytes were prepared as previously described (7) and resuspended in PBS-0.5% FBS. Cells were incubated with CD4 ϩ microbeads for 15 min at 6°C and then passed over a VS ϩ column on a SuperMACS magnetic cell separator. The column was removed from the separator and the cells were collected in PBS-0.5% FBS and counted. CD4
ϩ T cells at a ratio of 10:1 were overlaid onto antigen-presenting cells that were previously stimulated with antigens (as indicated above). The mixed cell cultures were then incubated for 72 h at 37°C and 5% CO 2 . In addition, IL-2 (Pepro Tech) at 5 U per well was added to support CD4 ϩ T-cell proliferation. In some experiments, cultures received 0.1 ng of murine recombinant IL-12 (Pepro Tech) per ml.
ELISA. Supernatants were assayed for IFN-␥ by a sandwich enzyme-linked immunosorbent assay (ELISA) using MAbs R4.6A2 and biotinylated XMG1.2 (BD PharMingen) as previously described (20) . IL-12 "total" (p40 and p70) or IL-12 p70 were detected using the Endogen mouse IL-12 total or IL-12 p70 ELISA. Sensitivity of the assay for IL-12 total was 12 pg/ml and for IL-12 p70 was Ͻ5 pg/ml.
RESULTS
Identification of dendritic cells in lung tissue from C57BL/6 mice. Lung tissue sections were stained with monoclonal antiCD11c (Fig. 1a and b) . Dendritic cells were present in the airway epithelium, close to the alveolar walls, interstitial spaces, ϩ lung cells were stained using Hema 3 stain after 7 days of culture and adherence on Thermovox coverslips. These cells had elongated morphology with very long cytoplasmic processes and large central nuclei (magnification, ϫ200). (e) In vitro infection of lung dendritic cells. Lung dendritic cells were infected in vitro at a ratio of 10 bacilli per cell. After overnight infection and centrifugation onto glass slides, cells were stained for acid-fast bacilli (arrows) using Ziehl-Neelsen stain (magnification, ϫ400).
and alveoli of lungs. At higher magnifications, lung dendritic cells showed a typical morphology, including a lobulated nucleus with abundant cytoplasm and small cytoplasmic projections. Figure 1c shows the morphology of lung dendritic cells after overnight culture. All the cells possessed large lateral nuclei, abundant cytoplasm, and small cytoplasmic projections and were of various sizes. The side panels show a higher magnification of dendritic cells with lateral nuclei and veiled morphology. Some were clearly in a state of mitosis.
When the cells were cultured in Thermovox coverslips, their dendritic nature could be more clearly seen, as demonstrated by long cytoplasmic processes and large central nuclei (Fig.  1d) .
To determine the ability of the harvested cells to engulf M. tuberculosis, lung dendritic cells were infected in vitro with 5 to 10 bacilli per cell. After overnight infection, the cells were centrifuged onto glass slides and stained for acid-fast bacilli. Intracellular bacilli were clearly evident (Fig. 1e) .
Cell surface marker expression by purified dendritic cells. Purified lung dendritic cells were analyzed by flow cytometry. After purification with CD11c microbeads, 80 to 90% of cells were CD11c ϩ (Fig. 2) . Based upon cell surface expression of CD11c and I-A b antigens, purified lung dendritic cells after overnight culture could be classified into three populations, as shown in Fig. 2 ϩ , and the total numbers of cells after 7 days in vitro increased two-to threefold compared to the number after the initial purification.
The flow cytometric analysis, described for the overnight culture, was also performed on the expanded 7-day lung dendritic cell culture. All cells were I-A b low and CD11c ϩ low to high and were similar to the R1 population from the overnight culture in Fig. 2 (data not shown). These cells were negative for the hemopoietic marker CD34, the peripheral blood marker CD14, and the lymphoid-related CD8␣ but expressed low levels of the myeloid marker F4/80 and moderate to high levels of MAC3 antigens (Fig. 3 ). All cells expressed high levels The results of this study are shown in Fig. 4 . Upregulation of the CD54 molecule and CD11a and CD11b for lung dendritic cells was seen after overnight infection (Fig. 4A) . In addition, lung dendritic cells infected for 48 h or cultured in the presence of TNF-␣ had an upward shift of the side scatter parameter (SSC) for both populations (Fig. 4B) . These cells also upregulated CD40 and I-A b antigens (Fig. 4B ). CD80 and CD86 antigens appeared to be upregulated only very late in infection (96 h) (data not shown). Bone-marrow-derived dendritic cells infected for 48 h presented the same pattern of upregulation of antigens as lung dendritic cells, but I-A b antigens were consistently upregulated to a higher level in the bone marrow-derived dendritic cells than in lung dendritic cells (Fig. 4C) .
IFN-␥ production by stimulated T cells. Lung dendritic cells were infected with M. tuberculosis at a ratio of 0, 1, 2, 5, or 10 CFU per cell and overlaid with purified naïve CD4 ϩ T cells.
After 72 h of culture, supernatants were assayed for the presence of IL-12 and IFN-␥. Figure 5b shows that lung dendritic cells were capable of stimulating naïve CD4 ϩ T cells to produce IFN-␥ in a dose-dependent manner. IL-12 total was also detected in these cultures in a dose-dependent manner (Fig.  5a ), but IL-12 p70 was not detected by ELISA, indicating either that it was not present or that the amount present in these cultures was below the sensitivity levels of the assay.
It has been reported before (9) that exogenous addition of murine IL-12 to cultures increases priming of naïve T cells by dendritic cells. We wanted to analyze if this was also true for M. tuberculosis-infected lung dendritic cells and naïve CD4
ϩ T cells, and we added IL-12 (0.1 ng/ml) to some cultures. Our results confirmed that exogenous addition of IL-12 increases by two-to threefold the production of IFN-␥ by naïve CD4 ϩ T cells when cultured with M. tuberculosis-infected lung dendritic cells (data not shown).
We then analyzed whether immune CD4 ϩ T cells obtained by intravenous inoculation of mice with M. tuberculosis were also stimulated by in vitro M. tuberculosis-infected lung dendritic cells. Figure 6 shows that immune CD4 ϩ T cells produced IFN-␥ when cultured in the presence of M. tuberculosisinfected lung dendritic cells or when cultured with CFPstimulated lung dendritic cells. 
DISCUSSION
The results of this study show that specialized macrophages exhibiting a dendritic morphology and expression of the CD11c cell surface marker (dendritic cells) are distributed widely throughout the mouse lung tissues. Examination of tissue sections stained with an antibody to CD11c indicated that these cells were present in airway epithelia as well as within the interstitial spaces in the alveolar regions, suggesting that these cells are judiciously placed for any interaction with invading pathogens. This distribution has been reported to be similar in both mice and rats (14, 15, 22) .
Isolation of these cells from the lung tissues revealed cells that were mostly circular. Compared to the total numbers of cells that could be harvested from the lungs, their numbers were low. Following flow cytometric analysis it was found that the great majority of these dendritic cells had a marker expression that is generally regarded by most studies (21, 27) as an immature phenotype, i.e., CD11c mid to high and major histocompatibility (MHC) class II low . A small number of cells, however, expressed high levels of I-A (Fig. 2) , which is indicative of a more mature phenotype that is usually associated with dendritic cells that have encountered an antigen and have undergone interactions with lymphocytes (6, 21) .
Previous reports (10, 12) have also described lung dendritic cells with high expression of cell surface MHC class II antigens. The bronchus-associated lymphoid tissue contains discrete Tand B-cell areas as well as interdigitating cells (3) and it may be that lung dendritic cells expressing high levels of MHC class II antigens could have interacted with T cells in the bronchusassociated lymphoid tissue and fully matured inside the lungs.
Harvested dendritic cells could be expanded by in vitro culture with GM-CSF, but most cells retained an immature phenotype. Expression of F4/80 and MAC3 was observed, but that of the myeloid progenitor marker CD34 or the lymphoid marker CD14 was not observed. It has also been suggested elsewhere (23) that a subset of mouse dendritic cells can be identified by the expression of the ␣ chain of CD8, but we failed to observe this in the lung dendritic cells (Fig. 3) . As anticipated, all dendritic cells expressed CD80, but only a few were seen to express CD40 or CD86. It has been demonstrated elsewhere (27) that this phenotype tends to identify large immature cells. Lung dendritic cells infected with M. tuberculosis and cultured overnight exhibited little change in the expression of CD40, CD80, CD86, and I-A antigens. By 48 h postinfection, however, CD40 and I-A antigens were upregulated. Despite the relative lack of costimulatory molecules on the overnight culture, these cells were still able to induce IFN-␥ secretion by naïve T cells. Presumably, when in an in vivo environment this efficiency is even higher; in this regard it has been shown elsewhere (4, 13) that CD40/40L ligation upregulates the expression of CD80 and CD86 on dendritic cells, increasing the production of IL-12 and leading to increased IFN-␥ secretion. Our own findings regarding the addition of exogenous IL-12 and stimulation of naïve CD4 T cells are in keeping with this.
Upregulation of MHC class II antigens after infection was consistently higher in bone-marrow-derived dendritic cells than in lung dendritic cells. Since both cells were cultured under the same conditions, it indicates that there are differences between both types of dendritic cells and that the origin of these cells may be an important factor to consider.
As stressed above, however, before dendritic cells can sensitize T cells they first have to reach them. We hypothesize that these cells take up bacilli from the interstitium and find their way to local lymphoid tissues in the bronchial region, eventually leading to the emergence of antigen-specific T cells. The fact that this will take a finite period of time may thus well explain why expression of acquired immunity in the lungs is such a slow event (5, 7) .
In keeping with our hypothesis, we have demonstrated here that infected dendritic cells quickly upregulate molecules that will allow them to pass through the extracellular matrix (integrins CD11a and CD11b) as well as cross-blood-vessel endothelial surfaces (CD54), actions that would be fully consistent with these cells acquiring a motile phenotype. This change in phenotype has been seen by others in cultures of blood-derived dendritic cells (8) but not in immortalized dendritic cell lines infected with M. tuberculosis (26) . In contrast, in the current study infection of dendritic cells with M. tuberculosis readily increased CD54 expression.
The concept that dendritic cells could be specifically targeted by new tuberculosis vaccine candidates is attractive. However, it is also clear that interactions between dendritic cells and T cells after their carriage of antigen to lymphoid tissues is a complex issue, in that not only are dendritic cells still relatively poorly understood, but the migratory routes of T-cell subsets, which appear to differ depending upon their selective expression of chemokine receptors such as CCR7 (24) , also appear to be a very complicated matter. 
